Skip to content

Loading your page…

Active substance · L01EH04

Zongertinib

On 2 registers2 medicines2 companies

See every medicineAsk Osler about it

Classification

Anatomical main groupLAntineoplastic and immunomodulating agents
Therapeutic subgroupL01Antineoplastic agents
Pharmacological subgroupL01E
Chemical subgroupL01EH
Chemical substanceL01EH04Zongertinib

Where it is registered

Each register with its number of medicines and a few of them.

Canada
Health Canada · 1 medicine
- Hernexeos60 MG · Tablet · Boehringer Ingelheim (Canada) LTD Ltee
United States
FDA · 1 medicine
- Hernexeos60MG · tablet · Boehringer Ingelheim

All medicines with Zongertinib

Every register, a page at a time. Strengths and packs are on each medicine’s page.

2 results

Medicine	Register	Strength	Form	Status	Holder
Hernexeos	United States	60MG	tablet	Marketed	Boehringer Ingelheim
Hernexeos	Canada	60 MG	Tablet	Authorised	Boehringer Ingelheim (Canada) LTD Ltee

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.